计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| L646669-5mg |
5mg |
期货 ![]() |
| |
| L646669-10mg |
10mg |
期货 ![]() |
| |
| L646669-50mg |
50mg |
期货 ![]() |
|
| 英文别名 | AKOS040741976 | compound 10 [PMID: 29562737] | SCHEMBL17334098 | LSZ 102 | 0Y175XGX4P | BL166455 | Q50825475 | AC-36747 | HY-111486 | UNII-0Y175XGX4P | US10058534, 139 | (E) -3- (4-((2-(2- (1,1-Difluoroethyl)-4-fluorophenyl)-6-hydroxybenzo[b]thiophen-3-yl |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | LSZ-102 |
| 生化机理 | LSZ-102 是一种强效、口服生物可利用的选择性雌激素受体降解剂,其 IC 50 为 0.2 nM。 |
| 储存温度 | -20°C储存,充氩 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 降解剂 |
| 产品介绍 |
LSZ-102 is a potent, orally bioavailable selective estrogen receptor degrader with an IC 50 of 0.2 nM. In Vitro LSZ-102 is a potent, orally bioavailable selective estrogen receptor degrader with an IC 50 of 0.2 nM and currently in Phase I/Ib trials for the treatment of ERα positive breast cancer. LSZ-102 induces significant degradation of ERα after 24 h, when given as a 10 μM solution to MCF-7 cells. Robust inhibition of cell proliferation in MCF-7 cells is observed upon incubation with LSZ-102 with a half inhibitory concentration of 1.7 nM. Results demonstrate that LSZ-102 effectively inhibits the estrogen-induced activation of the ERE-luciferase reporter using charcoal-stripped serum treated with E2 with IC 50 of 0.3 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Treatment of the mice with LSZ-102 once daily at 20 mg/kg results in significant tumor growth inhibition as compare to the control group treated with vehicle alone, resulting in tumor stasis (mean change in tumor volume of LSZ-102 vs control=%ΔT/ΔC of 2.4% on day 48, p<0.05). Dosing of 3 mg/kg solution of LSZ-102 in male Sprague-Dawley rats results in 33% bioavailability and a dose-normalized exposure of 620 nM•h . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:estrogen receptor |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | (E)-3-[4-[[2-[2-(1,1-difluoroethyl)-4-fluorophenyl]-6-hydroxy-1-benzothiophen-3-yl]oxy]phenyl]prop-2-enoic acid |
| INCHI | 1S/C25H17F3O4S/c1-25(27,28)20-12-15(26)5-9-18(20)24-23(19-10-6-16(29)13-21(19)33-24)32-17-7-2-14(3-8-17)4-11-22(30)31/h2-13,29H,1H3,(H,30,31)/b11-4+ |
| InChi Key | SJXNPGGVGZXKKI-NYYWCZLTSA-N |
| Smiles | CC(C1=C(C=CC(=C1)F)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)C=CC(=O)O)(F)F |
| Isomeric SMILES | CC(C1=C(C=CC(=C1)F)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)/C=C/C(=O)O)(F)F |
| 关联CAS | 2135600-76-7 |
| PubChem CID | 118574930 |
| MeSH Entry Terms | (E)-3-(4-((2-(2-(1,1-Difluoroethyl)-4-fluorophenyl)-6-hydroxybenzo(b)thiophen-3-yl)oxy)phenyl)acrylic acid;LSZ-102;LSZ102 |
| 分子量 | 470.46 |
| 溶解性 | DMSO : 100 mg/mL (212.56 mM; Need ultrasonic) H2O : <0.1 mg/mL (insoluble) |
|---|---|
| 分子量 | 470.500 g/mol |
| XLogP3 | 6.600 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 470.08 Da |
| 单同位素质量Monoisotopic Mass | 470.08 Da |
| 拓扑极表面积Topological Polar Surface Area | 95.000 Ų |
| 重原子数Heavy Atom Count | 33 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 712.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 1 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |